Xianbo Zuo

Xianbo Zuo

Auto-generated profile, based on publicly available information

Xianbo Zuo

Department of Pharmacy, China-Japan Friendship Hospital, Beijing, 100029, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Stroke
Verified
Journal Article
Closed access
LDLian Duan
Lian Duan
LWLing Wei
Ling Wei
YTYanghua Tian
Yanghua Tian
ZZZhengshan Zhang
Zhengshan Zhang
PHPanpan Hu
Panpan Hu
KWKai Wang
Kai Wang
Background and Purpose—: Moyamoya disease (MMD) is a rare cerebral vasculopathy characterized by bilateral internal carotid artery stenosis and often leads to stroke in children or young adults. Although familial inheritance is well recognized, the genetic basis of MMD remains poorly understood. Methods—: A 2-stage genome-wide association study was conducted involving 1492 cases and 5084 controls. In the discovery stage, logistic regression was used to test associations, and imputation was conducted based on genotyped single-nucleotide polymorphisms (SNPs). In the validation stage, the top significant SNPs were again genotyped in an independent cohort. Fixed-effects inverse variance-weighted meta-analysis was used in the combined discovery and validation samples. Furthermore, association analysis was conducted in subgroups using patient clinical data. Results—: The study identified 10 novel risk loci with genome-wide significance ( P <5×10 −8 ) and confirmed a previously reported locus on 17q25. No significant SNP showed evidence of heterogeneity between the 2 stages. Cumulatively, these SNPs explained 14.76% of disease risk variance—a substantial proportion of the 39.02% of risk variance explained by all genome-wide genotyped SNPs. One SNP, rs9916351 in RNF213 ( P combined =4.57×10 −54 ; odds ratio, 1.96), showed a stronger genetic effect on early-onset than late-onset MMD ( P =0.003). Two novel SNPs in genes regulating homocysteine metabolism, rs9651118 in MTHFR ( P combined =2.49×10 −19 ; odds ratio, 0.65) and rs117353193 in TCN2 ( P combined =6.15×10 −13 ; odds ratio, 1.43), were associated with high-serum homocysteine in MMD cases. Additionally, another SNP associated with MMD (rs2107595 in HDAC9 ; P combined =1.49×10 −29 ; odds ratio, 1.64) was previously implicated in large-vessel disease. Tissue enrichment analysis showed that the genes of associated loci were highly expressed in the immune system (false discovery rate, <0.05). Conclusions—: This study identifies several novel susceptibility genes for MMD. The association with homocysteine metabolism and the immune system enrichment of susceptibility gene expression suggest that therapeutic interventions targeting these pathways may be effective approaches for MMD treatment.

28 March 2015 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
YSYujun Sheng
Yujun Sheng
JXJian-Hua Xu
Jian-Hua Xu
YWYong-Gui Wu
Yong-Gui Wu
XZXian-Bo Zuo
Xian-Bo Zuo
JGJin-Ping Gao
Jin-Ping Gao
XZXuejun Zhang
Xuejun Zhang
Introduction: Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease. Currently, numerous genetic loci of SLE have been confirmed. Here we try to further explore additional genes contributing to SLE susceptibility in this study. Methods: Forty nine single nucleotide polymorphisms (SNPs) with moderate-risk for SLE in previous study were genotyped in a large-scale replication study with a total of 3,522 cases and 8,252 controls using the Sequenom Massarray system. Association analyses were performed using logistic regression with gender or sample cohorts as a covariate through PLINK 1.07 software. Results: This replication effort confirmed five reported SLE susceptibility loci reaching genome-wide levels of significance (P meta <5.00 × 10−08): TNFSF4 (rs1418190, odds ratio (OR) = 0.81, Pmeta = 1.08 × 10−08; rs4916219, OR = 0.80, Pmeta = 7.77 × 10−09), IRF8 (rs2934498, OR = 1.25, Pmeta = 4.97 × 10−09), miR-146a (rs2431697, OR = 0.69, Pmeta = 1.15 × 10−22), CD44 (rs2732547, OR = 0.82, Pmeta = 1.55 × 10−11), and TMEM39A (rs12494314, OR = 0.84, Pmeta = 1.01 × 10−09). Further logistic regression analysis indicated that the genetic effects within TNFSF4 detected in this study are independent from our previously reported signals. Conclusions: This study increases the number of established susceptibility loci for SLE in Han Chinese population and highlights the contribution of multiple variants of modest effect. Although further studies will be required to identify the causal alleles within these loci, the findings make a significant step forward in our understanding of the genetic contribution to SLE in Chinese population.

1 August 2019 in Journal of Affective Disorders
Verified
Journal Article
Closed access
ZFZhao Fuying
Zhao Fuying
YYYue Yingying
Yue Yingying
ZSZhang Shining
Zhang Shining
ZKZhang Kezhong
Zhang Kezhong
SYShi Yanyan
Shi Yanyan
YYYonggui Yuan
Yonggui Yuan

16 July 2023 in Pulmonary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
DZDan Zhang
Dan Zhang
XWXiaoxing Wang
Xiaoxing Wang
WDWenwen Du
Wenwen Du
WQWei Qin
Wei Qin
WCWenqian Chen
Wenqian Chen
PLPengmei Li
Pengmei Li

6 December 2023 in Pulmonary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
XWXiaoxing Wang
Xiaoxing Wang
WDWenwen Du
Wenwen Du
DZDan Zhang
Dan Zhang
WCWenhui Chen
Wenhui Chen
XZXianbo Zuo
Xianbo Zuo